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1. Introduction 
Transdermal delivery is one of the non-invasive methods for drug administration. Patient 
compliance is improved and continuous, sustained release of drug is achieved by 
following the application of transdermal formulation on the skin (Guy 1996; Tanner & 
Marks 2008). Transdermal drug delivery systems, known as patches, are dosage forms 
designed to deliver a therapeutically effective amount of drug across a patient’s skin in a 
predetermined time and controlled rate (Aulton 2007; Tiwary et.al., 2007; Vasil’ev  
et.al., 2001).  
Transdermal drug delivery systems can be divided into three main groups : a) adhesive 
systems, in which the drug in adhesive, b) matrix type systems in which the drug in a matrix 
polymer and c) reservoir systems (Delgado-Charro & Guy 2001; Williams, 2003). Although 
there are differences in the design of transdermal therapeutic systems, several features are 
common to all systems including the release liner, the pressure sensitive adhesive, and the 
backing layer (Walters and Brain, 2007).  
There are three critical considerations in the selection of a transdermal drug delivery 
system: adhesion to skin, compatibility with skin, and physical or chemical stability of 
total formulation and components (Walters and Brain, 2007). The adhesive nature of the 
patches is critical to the safety, efficacy, and quality of the product. Therefore the three 
important performance tests to monitor adhesive performance of patches are tack, shear 
strength and peel adhesion (Gutschke et al., 2010; Patel and Baria 2011; Ren et al., 2009). 
The choice and design of polymers, adhesives, penetration enhancers and plasticizers in 
transdermal patches are also critical because they have a strong effect on drug release, 
permeability, stability, elasticity, and wearing properties of transdermal drug delivery 
systems (Quan, 2011).  
Plasticizers are low molecular weight resins or liquids, which cause a reduction in polymer-
polymer chain secondary bonding, forming secondary bonds with the polymer chains 
instead (Gal and Nussinovitch, 2009; Rajan et al., 2010). The reasons for the use of 
plasticizers in transdermal drug delivery systems are the improvement of film forming 
properties and the appearance of the film, decreasing the glass transition temperature of the 
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polymer, preventing film cracking, increasing film flexibility and obtaining desirable 
mechanical properties (Wypych, 2004). One of the many advantages of plasticizers used in 
transdermal formulations is the controlling of the release rate of therapeutic compound 
which can be done by the selection of the plasticizer type and the optimization of its 
concentration in the formulation. The commonly used plasticizers in transdermal patches 
include phthalate esters, phosphate esters, fatty acid esters and glycol derivatives 
(Bharkatiya et al, 2010; Wypych, 2004).  
The objectives of this chapter are to summarize the compositions and types of the 
transdermal drug delivery systems; to emphasize the role and effectiveness of plasticizers in 
transdermal drug delivery systems and to cover the research studies and current 
developments related to the development of transdermal formulations. 
2. Transdermal drug delivery systems 
Transdermal drug delivery systems, also known as “patches”, are dosage forms designed to 
deliver a therapeutically effective amount of drug across a patient’s skin in a predetermined 
time at controlled rate and to maintain constant drug plasma concentration over a long 
period (Aulton 2007; Vasil’ev et.al., 2001). Transdermal patches have superiorities such as 
improved patient compliance and flexibility of dosage in which formulation can be removed 
immediately (Brown et.al. 2006; Guy 1996; Tanner & Marks 2008; Williams 2003). The 
transdermal systems of drugs including scopolamine, nitroglycerin, isosorbide dinitrate, 
clonidine, estradiol, fentanyl, nicotine, testosterone, norelgestromin+ethinyl estradiol, 
oxybutynin, selegeline, methylphenidate, buprenorphine, rivastigmine, rotigotine and 
granisetron have been approved (Guy 2010). 
The major technical considerations by developing a transdermal formulation include 
(Meathrel, 2011; Quan, 2011): 
 Size of the drug molecule and the required daily dose 
 Drug compatibility with polymers, adhesives, plasticizers and other excipients used in 
the formulation 
 Physical and chemical stability of the final formulation 
 Size of the patch 
 Balance between adhesion and easy patch removal depending on the duration of patch 
application. 
2.1 Types of transdermal drug delivery systems 
Although transdermal systems are classified in different types, transdermal patches can be 
divided into three main categories depending on the incorporation style of the drug in the 
system (Figure 1): (Delgado-Charro & Guy 2001; Padula et.al. 2007; Vasil’ev et.al., 2001;  
Williams, 2003). 
 Reservoir Systems 
 Matrix Systems 
 Adhesive Systems 
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Fig. 1. Schematic representation of transdermal patch types: A. Reservoir, B. Matrix,  
C. Drug-in-Adhesive transdermal systems. 
a. Reservoir Systems: In these systems, the drug is in a reservoir as liquid. Drug 
molecules are contained in the storage part, as a suspension in a viscous liquid or 
dissolved in a solvent. In the second type, there is a membrane made of a polymer with 
different structure, which separates the reservoir from the adhesive layer. In these 
systems, the membrane controls the release rate of the drug. The membrane can be 
porous or nonporous. The adhesive polymer on the exterior surface of the membrane 
enables the transdermal to adhere to skin. In these systems, drug release rate can be 
controlled by membrane thickness and adhesive layer (Delgado-Charro & Guy 2001; 
Padula et.al. 2007; Williams, 2003). 
Transderm-Nitro (Nitroglycerin), Transderm-Scop (Scopolamine), Catapress-TTS 
(Clonidine), Estraderm (Estradiol) can be given as examples to the commercially available 
membrane diffusion controlled systems. 
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b. Matrix Systems: In this type of systems, the drug is dispersed homogeneously within a 
polymer matrix which has hydrophilic or lipophilic character. Outer side of the 
formulation is covered with a backing layer. In these systems, patch is held on the skin 
with a adhesive polymer as a strip. Matrix type formulations can also be prepared by 
dispersing the drug in an adhesive polymer that is sensitive to direct pressure and then 
covering this system with an impermeable backing layer. Since in matrix type 
formulations, release from semi-solid matrix of the drug is not controlled by any 
membrane, drug release from these systems is related to the surface area to which the 
patch is applied (Delgado-Charro & Guy 2001; Padula et.al. 2007; Williams, 2003). 
Minitran (Nitroglycerin), Emsam (Selegeline), Exelon (Rivastigmine), Sancuso (Granisetron) 
and Oxytrol (Oxybutyne) can be given as examples to commercially available matrix 
diffusion controlled systems.  
c. Adhesive Systems: In these systems, drug reservoir is prepared by dispersing the drug 
in an adhesive polymer. At the outmost, an impermeable backing layer takes place. 
Under the drug reservoir layer, there exists an adhesive membrane controlling the drug 
release rate. In this type of transdermal systems, drug release rate is controlled both by 
the matrix in which the drug is dispersed and also by a membrane. Although this type 
of systems can be designed with a single drug layer, they can be also designed as multi-
layered (Delgado-Charro & Guy 2001; Padula et.al. 2007; Williams, 2003).  
Nitrodur (Nitroglycerin), Daytarana (Methyl phenidate) and Duragesic (fentanyl) can be 
given as examples to commercially available adhesive systems.  
2.2 Composition of transdermal drug delivery systems 
Although transdermal systems can be design as different type systems mentioned above, 
following are the basic components which generally are used in the formulations of almost 
all type of transdermal patches (Williams, 2003). 
 Drug 
 Matrix 
 Reservoir 
 Semi-permeable (release) membrane 
 Adhesive  
 Backing layer 
 Release liner  
 Solvents, penetration enhancers  
 Plasticizers 
a. Drug: The drug, of which transdermal system will be designed, should possess some 
physicochemical characteristics. Drug should have relatively low molecular weight 
(<500 Dalton), medium level lipophilic character (log P 1-3.5) and water solubility (>100 
mcg/ml). Also, the drug should be a potent compound, which is effective at low dose 
(<20 mg) (Guy 1996; Quan 2010).  
b. Matrix: In the formulation of matrix type transdermal systems, the drug is dispersed or 
dissolved in a polymer matrix (Delgado-Charro & Guy 2001; Williams 2003). This 
matrix with polymer structure controls the release rate of the drug. Natural (e.g. pectin, 
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sodium alginate, chitosan), synthetic (Eudragit, polyvinyl pyrolidon, PVA) and semi-
synthetic polymers (e.g. cellulose derivatives) are used as polymer (Amnuaikit et al., 
2005; Güngör et al., 2008; Lin et al., 1991; Nicoli et al., 2006; Schroeder et al., 2007,a).  
c. Reservoir: In this type of transdermal patches, a semi-permeable membrane controlling 
the drug release rate is used. The drug presents in a reservoir as liquid or solid 
(Delgado-Charro & Guy 2001; Williams 2003). 
d. Semipermeable (release) membrane: It takes place in reservoir type transdermal systems 
and multi-layer adhesive systems. Ethylene-vinyl acetate copolymer, silicones, high- 
density polyethylene, polyester elastomers, cellulose nitrate and cellulose acetate are used 
as membrane. These membranes control the release rate of drugs (Williams 2003). 
e. Adhesive: Adhesive should enable the transdermal system to easily adhere to the skin 
and should not be irritant/allergen for skin. Generally, pressure-sensitive adhesives are 
used in transdermal systems. Commonly used pressure-sensitive adhesives are 
collected under 3 classes as a) acylates, b) polyisobutilene adhesives and c) polysiloxan 
adhesives (Williams 2003).  
f. Backing layer: It protects the system from external effects during administration and 
ensures integrity of the system in the storage period. For this purpose, the materials 
impermeable for drug molecule are used as backing layer. The backing layer must be 
inert and not compatible with the drug and other substances used in the formulation. 
Generally, ethylene vinyl acetate, polyethylene, polypropylene, polyvinylidene chloride 
and polyurethane are used as backing layer (Williams 2003). 
g. Release liner: This is the part which protects the formulation from external 
environment and which is removed before the system is adhered to skin. Ethylene vinyl 
acetate, aluminum foil or paper can be used. Ideally, it should be easily peeled from the 
adhesive layer and should not damage the structure of adhesive layer. Also, silicone, 
fluorosilicone, perfluorocarbon polymers can be used (Williams 2003). 
h. Solvents, penetration enhancers: Various solvents are used to solve or disperse the 
polymer and adhesive or drug used in preparation of the transdermal systems. Among 
those, chloroform, methanol, acetone, isopropanol and dichloromethane are used 
frequently. Also, various penetration enhancer substances are added to the 
formulations to increase permeation from skin of the drug. Terpenes, fatty acids, water, 
ethanol, glycols, surface-effective substances, azone, dimethyl sulfoxide are widely used 
in the transdermal formulations as permeation enhancer (Williams 2003).  
i. Plasticizers: In transdermal systems, plasticizers are used to improve the brittleness of 
the polymer and to provide flexibility (Williams 2003). 
3. Plasticizers  
Plasticizers are generally non-volatile organic liquids or solids with low melting 
temperature and when added to polymers, they cause changes in definite physical and 
mechanical characteristics of the material (Bharkatiya et al, 2010; Felton, 2007; Gooch, 
2010; Meier et al., 2004).  
3.1 The role of plasticizers in pharmaceutical formulations 
The main reasons of adding plasticizers to polymers, improving flexibility and 
processability are counted (Harper, 2006; Höfer & Hinrichs, 2010; Rahman & Brazel, 2004; 
Whelan, 1994). Upon addition of plasticizer, flexibilities of polymer macromolecules or 
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macromolecular segments increase as a result of loosening of tightness of intermolecular 
forces (Bergo & Sobral, 2007; Höfer & Hinrichs, 2010). 
The plasticizers with lower molecular weight have more molecules per unit weight 
compared to the plasticizers with higher molecular weight. These molecules can more easily 
penetrate between the polymer chains of the film forming agent and can interact with the 
specific functional groups of the polymer (Gal & Nussinovitch, 2009).  
By adding plasticizer to a polymeric material, elongation at break, toughness and flexibility 
are expected to increase, on the other hand tensile stress, hardness, electrostatic 
chargeability, Youngs modulus and glass transition temperature are expected to decrease 
(Gal & Nussinovitch, 2009; Harper, 2006; Rahman & Brazel, 2004). 
Plasticizers with low molecular weight, act by reducing the secondary bonds (e.g. hydrogen 
bond) of the polymer chains and themselves forming secondary bonds (Gal & Nussinovitch, 
2009). While low molecular weight improves miscibility with the polymer, the second factor 
increasing the compatibility is the realization of strong mutual hydrogen bonding (Harper, 
2006). Thus, weakening of interaction of the polymer chains decrease tensile strength and 
glass transition temperature and so the flexibility of polymer films increases (Felton, 2007; 
Rahman & Brazel, 2004). 
3.2 Classification of plasticizers 
Several substances, including water, can be used to plasticize the polymer. It is reported 
that, phthalate, sebacate and citrate esters are among the most commonly used plasticizers 
(Felton, 2007). Compatibility, general structure (being a monomeric or polymeric), functions 
and chemical structure are taken into account in classifying the plasticizer substances 
(Gooch, 2010). 
Most used group of the plasticizer substances is the phthalic acid esters which have firstly 
put into use in 1920. Dioctyl-phthalate is the most commonly used phthalic acid ester and it 
constitutes 50% of the world’s plasticizer consumption (Höfer & Hinrichs, 2010).  
Aliphatic ester plasticizers are derived from esterification of adipic, sebacic and azelaic acids 
with linear or branched monofunctional alcohols of short or medium length of chain (e.g. 
dioctyladipate and dibutylsebacate). Adipate, azelate and sebacate plasticizers are 
distinguished from other groups by their low viscosity. They give flexibility to the polymers 
they are used together at low temperatures (Harper, 2006; Höfer & Hinrichs, 2010; Rahman 
& Brazel, 2004).  
Phosphate esters and various glycol derivatives such as propylene glycol and polyethylene 
glycol are also employed to plastify the polymeric films (Felton, 2007; Harper, 2006; Meier et 
al., 2004; Rahman & Brazel, 2004). 
It has been reported that, surfactants, preservatives and other compounds also function as 
plasticizer agent together with cellulosic and acrylic polymers (Felton, 2007). 
3.3 Properties of plasticizers  
A plasticizer is firstly expected to be compatible with the polymer substance. This means 
that, it can fully mix with the polymer and can remain permanently in the polymer. 
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Tendency to migration, exudation, evaporation or volatilization of the plasticizers employed 
in a polymeric system must be low (Felton, 2007; Harper, 2006). 
Other properties expected from an ideal plasticizer are its workability, its ability to provide 
desired thermal-electrical and mechanical characteristics to the end product, its durability at 
high and low temperature values, its being effective over a wide temperature range and not 
being affected by ultraviolet radiation, its cost being low and its conformance to the health 
and safety arrangements (Rahman & Brazel, 2004). 
3.4 Effectiveness of plasticizers  
While some of approximately 600 commercial plasticizers are very effective in softening the 
polymers, the others do not exhibit efficiency in this area and are used for different purposes 
(Harper, 2006). To exhibit efficiency, the plasticizer should be able to transit from solvent 
phase to polymer phase and then it can diffuse into polymer and disrupt the intermolecular 
interactions (Felton, 2007). 
Three factors determine the effectiveness of a plasticizer to be used with polymers (Harper, 
2006): 
1. A flexible plasticizer molecule with long (CH2)n chains is more effective in increasing 
the polymer flexibility. 
2. Low polarity and hydrogen bonding cause decrease in the interaction between the 
polymer and the plasticizer (borderline compatibility). 
3. The plasticizers with low molecular weight are more active and they increase the 
flexibility more. 
The forces affecting the polymer-plasticizer mixtures are identified as hydrogen bonds, 
dipole-dipole interactions and dispersion forces. The methods used in measuring the extent 
of polymer plasticizer interaction can be listed as follows (Felton, 2007): 
 Torsion braid pendulum 
 Vapor pressure depression 
 Osmotic pressure 
 Swelling tests 
 Gas-liquid chromatography  
 Viscometry 
 Melting point depression 
 Nuclear magnetic resonance (NMR) Spectroscopy 
 Fourier Transform Infrared (FTIR) Spectrometry 
Plasticizers are generally compared with a plasticizer with well known characteristics such 
as dioctylphthalate. A characteristic such as modulus or hardness is chosen and a value for 
this characteristic is determined. The ratio of plasticizer concentrations 
(test/dioctylphthalate) required to achieve this value is defined as the effectiveness of the 
plasticizer (Whelan, 1994). The effectiveness can also be measured by graphing the modulus 
versus plasticizer concentration and the graphs of various plasticizers can be compared 
(Harper, 2006). Most commonly used methods in measuring the effectiveness of the 
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plasticizer are DSC analyses and the decrease in glass transition temperature when 
plasticizer is added to polymer (Felton, 2007; Zhu et al., 2002). 
In pharmaceutical formulations, effectiveness of a plasticizer agent substantially depends on 
its amount added to the formulation and on the polymer-plasticizer interaction. When an 
aqueous dispersion is in question, the proportion and amount of partition was found to be 
dependent on the solubility of the plasticizer in water and its affinity to the polymer phase. 
When water-insoluble plasticizers will be dispersed in an aqueous medium, they should 
firstly be emulsified and then added to the polymer (Felton, 2007). 
4. Plasticizers in transdermal drug delivery systems  
Many of the polymers used in pharmaceutical formulations are brittle and require the 
addition of a plasticizer into the formulation. Plasticizers are added to pharmaceutical 
polymers intending to ease the thermal workability, modifying the drug release from 
polymeric systems and improving the mechanical properties and surface properties of the 
dosage form (Felton, 2007; Lin et al., 2000; Wang et al., 1997; Wu & McGinity, 1999; Zhu et 
al., 2002).  
The plasticizers used in pharmaceutical formulations present a) in coating material of solid 
dosage forms, and b) in transdermal therapeutic systems. The list of frequently used 
plasticizers in pharmaceutical formulations is given below (Table 1) (Wypch, 2004).  
 
Group Hydrophilic/Lipophilic Plasticizer 
Glycerol and esters Hydrophilic 
Glycerine, Glycerine triacetate,  
Glyceryltributyrate 
Glycol derivatives Hydrophilic 
Propylene glycol, Poliethylene 
glycol 
Phthalic acid esters Lipophilic 
Dibutyl phthalate, Diethyl 
phthalate 
Sebacic acid esters Lipophilic Dibutyl sebacate, Diethyl sebacate 
Oleic acid esters Hydrophilic Oleil oleate 
Sugar alcohols Hydrophilic Sorbitol  
Citric acid esters Hydrophilic Triethyl citrate, Tributhyl citrate  
Tartaric acid esters Lipophilic Diethyl tartarate 
Table 1. Plasticizers Used in the Pharmaceutical Formulations (Wypch, 2004). 
It is observed that the plasticizers added to transdermal therapeutic systems are mostly used 
in the proportions between 5-20%. The chemical formulas of 6 plasticizers frequently used in 
transdermal drug delivery studies are given in Table 2.  
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 Glycerine 
 
 Propylene Glycol 
 
 
 Dibutyl Phtalate 
 
 Triethyl citrate 
 
 
Triacetin 
 
Polyethylene Glycol 
 
 
 
Table 2. The chemical formulas of the frequently used plasticizers in transdermal 
formulations. 
Among the plasticizers commonly used in the formulation of transdermal films, there are 
the phthalate and citrate esters and glycol derivatives (Gal & Nussinovitch, 2009). The 
plasticizers used in the studies conducted through last 20 years, their proportions and the 
polymers they are used with are given as a table (Table 3). 
Following are the reasons which can be counted among those for adding plasticizers to the 
polymer films to be used in transdermal drug delivery systems: 
 Reducing the brittleness 
 Improving flow 
 Ensuring flexibility 
 Enhancing the resistance and tear strength of the polymer film (Bergo & Sobral, 2007; 
Felton, 2007; Rao & Diwan, 1997).  
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Plasticizer  % w/w Polymer 
Type of 
Transdermal 
Formulation 
Reference 
Triacetin 
1.43-
5.48 
Eudragit E 100 
Drug free 
film 
Lin et al., 1991 
Sorbitol 
Sucrose 
20 
Polyvinyl Alcohol: 
Chitosan 
Drug free 
film 
Arvanitoyannis et al., 
1997 
Dibutyl phthalate 
Propylene glycol 
Polyethylene 
glycol 600 
40  Cellulose acetate 
Drug free 
film  
Rao & Diwan, 1997 
Polyethylene 
glycol 3350 
5 
Hydroxypropylcellulose 
Hydroxypropylcellulose: 
Eudragit E 100 
Hydroxypropylcellulose: 
Carbopol 971P 
Hydroxypropylcellulose: 
Polycarbophil 
Matrix Repka & McGinity, 2001 
Polyethylene 
glycol 600 
10-50 Cellulose Acetate Membrane Wang et al., 2002 
Triethyl citrate 
Dibutyl phthalate  
10 Eudragit E 100 Matrix 
Gondaliya & 
Pundarikakshudu, 2003 
Glycerine 4 Polyvinyl Alcohol 72000 Matrix Padula et al., 2003 
Polyethylene 
glycol 400 
40 Carboxymethyl Guar Matrix Murthy et al., 2004 
Dibutyl phthalate  30 
Ethyl cellulose 
Polyvinylpyrrolidone 
Matrix Amnuaikit et al., 2005 
Dibutyl phthalate 20 
Ethyl cellulose: 
Polyvinylpyrrolidone 
Eudragit: 
Polyvinylpyrrolidone 
Matrix Mukherjee et al., 2005 
Sorbitol Solution 
(70%) 
2 Polyvinyl Alcohol Matrix Nicoli et al., 2005 
Sorbitol Solution 
(70%) 
4 Polyvinyl Alcohol 83400 Matrix Femenia-Font et al., 2006 
Sorbitol Solution 
(70%) 
4 Polyvinyl Alcohol Matrix Nicoli et al., 2006 
Dibutyl phthalate 30 
Ethylcellulose: 
Polyvinylpyrrolidone 
Matrix Dey et al., 2007 
Dibutyl phthalate 
Propylene Glycol 
20 
Polyvinyl Alcohol  
Xanthan Gum 
Matrix Kumar et al., 2007 
Triethyl citrate 6 
Hydroxypropylcellulose  
Eudragit RL PO 
Silicon Gum 
Acrylate copolymer 
Film 
forming 
polymeric 
solution 
Schroeder et al., 2007,a 
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Plasticizer  % w/w Polymer 
Type of 
Transdermal 
Formulation 
Reference 
Triethyl citrate 
Triacetin 
Dibutyl phthalate 
1-6 
2.1 
4 
Eudragit RL PO, E100, S100 
and NE 40D 
Polyvinylpyrrolidone 
Hydroxypropylcellulose  
Acrylate copolymer 
Acrylate/Octylacrylamide 
copolymer 
Silicon Gum 
Polyvinyl Alcohol  
Polyisobutylene 
Film 
forming 
polymeric 
solution 
Schroeder et al., 2007, b 
Tributyl citrate 
Triacetin 
25-125 Eudragit NE40D Matrix Cilurzo et al., 2008 
Propylene glycol 10 Pectin Matrix Güngör et al., 2008 
Triacetin 20 
Eudragit E 100: Eudragit 
NE40D 
Matrix Inal et al., 2008 
Dibutyl phthalate 
Triethyl citrate 
30 
Hydroxypropyl methyl 
cellulose:Ethyl cellulose 
Matrix 
Limpongsa &  
Umprayn, 2008 
Glycerin 
Polyethylene 
glycol 400 
Propylene Glycol 
20, 40 
Polyvinyl Alcohol  
Polyvinylpyrrolidone 
Matrix Barhate et al., 2009 
Triacetin 10-45 Eudragit E 100 Matrix Elgindy & Samy, 2009 
Glycerin  
Polyethylene 
glycol 200 
Polyethylene 
glycol 400 
10  
Polyvinyl Alcohol : 
Polyvinylpyrrolidone 
Matrix Gal & Nussinovitch, 2009 
Propylene Glycol 
Dibutyl phthalate 
30 
30 
Polyvinyl Alcohol: 
Polyvinylpyrrolidone 
Ethyl cellulose: 
Polyvinylpyrrolidone 
Matrix Jadhav et al., 2009 
Propylene Glycol  
Polyethylene 
glycol 400 
5, 10 
Eudragit L100 
Eudragit L100-55 
Eudragit S100 
Matrix Marzouk et al., 2009 
Propylene Glycol 
20, 
30,40 
Hydroxypropyl methyl 
cellulose 
Ethyl cellulose 
Carboxy methyl cellulose 
Matrix Pandit et al., 2009 
Dibutyl phthalate  30 
Ethyl cellulose: 
Polyvinylpyrrolidone 
Ethyl cellulose: 
Hydroxypropyl methyl 
cellulose 
Matrix 
Bagchi &  
Kumar Dey, 2010 
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Plasticizer  % w/w Polymer 
Type of 
Transdermal 
Formulation 
Reference 
Dibutyl phthalate 
Propylene Glycol 
Polyethylene 
glycol 400 
40 
Cellulose acetate 
Hydroxypropyl methyl 
cellulose  
Polyvinylpyrrolidone 
Polyethylene glycol 4000 
Eudragit RL 100-RS 100 
Matrix Bharkatiya et al., 2010 
Propylene Glycol 15 
Hydroxypropyl methyl 
cellulose E15: Eudragit RS 100  
Hydroxypropyl methyl 
cellulose E15: Eudragit RL 
100 
Matrix Karunakar et al., 2010 
Propylene Glycol 20 
Hydroxypropyl methyl 
cellulose 
Eudragit RL 100 
Bilayered 
Matrix 
Madishetti et al., 2010 
Propylene Glycol 20 
Eudragit RL 100 
Hydroxypropyl methyl 
cellulose 
Matrix Mamatha et al., 2010 
Polyethylene 
glycol 400 
Dibutyl phthalate 
Glycerin 
15, 
30,40 
Gum Copal Matrix Mundada & Avari, 2010 
Sorbitol 
Glycerin 
4 Polyvinyl Alcohol 29, 83,115 Matrix Padula et al., 2010 
Dibutyl phthalate 
Dibutilsebacate 
5, 10 
Eudragit E100 
Polyvinylpyrrolidone 
Matrix Rajabalaya et al., 2010 
Dibutyl phthalate 5-25 
Eudragit RS 100, Eudragit RL 
100, Polyvinylpyrrolidone 
Matrix Rajan et al., 2010 
Triethyl citrate 5 
Hydroxypropyl methyl 
cellulose, Eudragit RL 100, 
Chitosan 
Matrix Shinde et al., 2010 
Polyethylene 
glycol 400 
5, 10 
Eudragit RL 100 
Eudragit RS 100 
Matrix Amgoakar et al., 2011 
Glycerin 10 
Polyvinyl Alcohol 
Polyvinylpyrrolidone 
Trimethoxysilane 
Matrix Guo et al., 2011 
Glycerin  
10, 20, 
30 
Hydroxypropyl methyl 
cellulose  
Polyvinylpyrrolidone 
Eudragit RS100 
Matrix Irfani et al., 2011 
Glycerin 5 
Polyvinyl Alcohol:Eudragit 
L30D55 
Matrix Nesseem et al., 2011 
Dibutyl phthalate 10 
Ethyl cellulose 
Hydroxypropyl methyl 
cellulose 
Matrix Parthasaraty et al., 2011 
Table 3. The plasticizers used in the transdermal studies conducted through last 20 years, 
their proportions and the polymers they are used with. 
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The selection of plasticizers depends on the characteristics of polymer used to prepare 
transdermal formulation. When the composition of transdermal film/patch formulations in 
the patents was looked over, it was seen that polyvalent alcohols e.g. glycerin and 1,2 
propandiol (propylene glycol) are generally used as plasticizers to softening the polymers in 
the formulation (Deurer et.al. 1999; Herrmann & Hille, 1999; Selzer 2001; Selzer, 2004). 
Higher alcohols such dodecanol, or mineral oil, silicone oil, isopropyl myristate; isopropyl 
palmitate; polyethylene glycol 400; diethyl sebacate and/or dibutyl sebacate; hydrocarbons, 
alcohols, carboxylic acids and derivatives thereof were also added into transdermal 
formulations as plasticizer (Petereit et.al. 2005; Salman & Teutsch 2011; Selzer, 2001). 
Without a plasticizer, a very hard but brittle film is obtained. This means that, external 
forces such as bending, stretching and stripping from surface will cause tearing of the film 
without too much effort. However, when transdermal patches are in question, rather than 
reduction in the hardness of the patch, its endurance when positioned or repositioned on the 
skin is important (Gal & Nussinovitch, 2009). 
In studying the mechanical properties of transdermal patches or films, tensile testing is the 
primarily interested subject. Tensile tests enable to study the mechanical properties of the 
formulation such as stress strain curves and stress at failure. These properties provide 
information about the resistance to damage during storage and usage. The effect of the type 
and proportion of the plasticizer in a formulation on the mechanical properties can also be 
understood by this way (Gal & Nussinovitch, 2009; Rajabalaya et al., 2010).  
The tensile strength of the transdermal films varies with the type of the polymer and 
plasticizer used. Generally a soft and weak polymer is identified with low tensile strength 
and low elongation values, a hard and brittle polymer is identified with moderate tensile 
strength and low elongation values and a soft and tough polymer is identified with high 
tensile strength and high elongation values (Bharkatiya et al., 2010). 
Barhate et al. have prepared matrix type transdermal patches using polyvinyl alcohol and 
polyvinyl pyrolidone as polymer and using glycerin, polyethylene glycol 400 and propylene 
glycol in proportions 20% and 40% as plasticizer and studied carvedilol permeation from 
these patches. Plasticizers used have ethylene oxide groups and display their effects thanks 
to the hydrogen bonds they form with polymer molecules. This interaction gives flexibility 
to the polymer. Tensile strength measures the ability to patch to withstand rupture. In the 
formulations prepared, highest tensile strength has obtained when glycerine was used as 
plasticizer. On the other hand, it was determined that in vitro permeation of carvedilol 
increased when polyethylene glycol 400 was used (Barhate et al., 2009). 
Drug free polymeric patches have been prepared using various polymers (Eudragit, 
hydroxypropylmethyl cellulose, cellulose acetate, polyvinyl pyrolidone and polyethylene 
glycol 4000) and effect of various plasticizers on mechanical and physicochemical properties 
of the patches have been investigated. Polyethylene glycol 400, dibutyl phthalate and 
propylene glycol were used as plasticizer in proportion of 40% (w/w) of the weight of the 
dry polymer. Tensile strength and folding endurance properties of the patches prepared 
with dibutyl phthalate have been found higher compared to those prepared with propylene 
glycol and polyethylene glycol 400 (Bharkatiya et al., 2010). 
www.intechopen.com
 
Recent Advances in Plasticizers 
 
104 
In a study conducted with cellulose acetate transdermal films, it has been determined that 
when dibutyl phthalate and polyethylene glycol 600 have been used as plasticizer, the 
transparency of the films were not differing from the films not containing plasticizer, on the 
other hand, when propylene glycol has been used, it created a light opaqueness. Besides, the 
flexibility of the films plasticized with 40% plasticizer has been determined to be much 
better than unplasticized films and they could be removed without rupture from the surface 
they were adhered to (Rao & Diwan, 1997). 
In a study where polyvinyl alcohol and polyvinyl alcohol-Xanthan gum mixture has been 
used as polymer, propylene glycol and dibutyl phthalate have been chosen as plasticizer. It 
has been observed that, addition of xanthan gum and dibutyl phthalate to the films 
prepared with only polyvinyl alcohol decreases the tensile strength and increases the 
percentage elongation. On the other hand, in polyvinyl alcohol films prepared with 
propylene glycol, tensile strength has been found higher. Besides, in vitro release of the 
terbutaline sulphate, which is an active substance, has been found higher in the propylene 
glycol containing films (Kumar et al., 2007). 
Eudragit E 100, is a good polymer candidate in preparing transparent and self-adhesive 
transdermal films. However, its mechanical properties should be enhanced by adding a 
plasticizer. In a study evaluating drug free Eudragit E 100 films, it has been observed that 
elongation value of the films has increased depending on the increase of concentration of 
plasticizer. Triacetin used as plasticizer in combination with a cohesion promoter, succinic 
acid. It is thought that, the plasticizer ensures this effect with lubrication of the polymer 
chains. Differential Scanning Calorimetry (DSC) analyses have shown that, the crystallinity 
was decreased in plasticized Eudragit E 100 films when compared with those not 
plasticized. Increase in the mobility of the polymer chains and corresponding decrease in 
the crystallized area existing within the polymer are expected to enhance the active 
substance permeation. It has been concluded that, best cohesion promoter-plasticizer 
combination for Eudragit E 100 films was 7% succinic acid and 25% or 45% triacetine 
(Elgindy & Samy, 2009).  
Although triacetin is considered as a good plasticizer for Eudragit E transdermal films, it 
has been determined that, addition of a secondary plasticizer such as polyethylene glycol 
200, propylene glycol, diethyl phthalate or oleic acid to the system positively affects the 
transparency, flexibility and adhesive properties of the film (Lin et al., 1991). 
Addition of plasticizer to the transdermal therapeutic systems may exhibit a facilitating 
effect in adhesion of the film to the other surfaces or membranes, by affecting the 
adhesiveness of the system (Gal & Nussinovitch, 2009; Rao & Diwan, 1997). Again in 
transdermal systems, humidity content and water absorption capacity of the system are 
measured and effect of the plasticizers on these values is researched (Rajabalaya et al., 2010). 
Water vapor transmission rate is closely related with the permeability characteristics of the 
transdermal films and can change according to the plasticizer and polymer type used 
(Bharkatiya et al, 2010).  
It has been reported that, the plasticizers such as glycerine, sorbitol and polyethylene glycol 
can change release rate of the therapeutic components contained in the formula of 
transdermal drug delivery systems. Release rate of the drug can be adjusted by changing the 
type and concentration of the plasticizer (Lin et al., 2000; Wypch, 2004). Also it has been 
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found that, the effect of the plasticizer on drug transport is related to the physicochemical 
properties of the permeant, in particular to its solubility in the plasticizer (Padula et al., 
2010).  
In transition studies conducted with diltiazem hydrochloride and indomethacine, diffusion 
of the drug has been found as the films plasticized with polyethylene glycol 600 > dibutyl 
phthalate > propylene glycol, in order. It has been concluded that, permeation of the drugs 
and mechanical properties of the film were affected by the choice of suitable plasticizer and 
its concentration (Rao and Diwan, 1997). 
In their study, Amgokar and coworkers have prepared transdermal films of budesonide. In 
the films, Eudragit RL 100: Eudragit RS and ethylcellulose-polyvinylpyrolidone (in 
proportions of 7:3 and 7:2, respectively) have been used as polymers and polyethylene 
glycol 400 has taken place as plasticizer. While drug release has found proportional to the 
polymer concentration, increase in the plasticizer amount has caused an increase in the 
weight of the film. It has also been observed that, increase in the plasticizer amount has also 
increased the humidity absorption of the transdermal films. It has been reported that, 
permeation of budesonide was the highest when polyethylene glycol 400 has been used in 
proportion of 10% (Amgaokar et al., 2011). 
Irfani and coworkers have used different combinations of hydoxypropyl methylcellulose, 
Eudragit RS 100 and polyvinylpyrolidone, when preparing transdermal films of the active 
substance, valsartan. In the formulations, different proportions (10%, 20% and 30%) of 
glycerin have been tried as plasticizer. It has been found that, increasing plasticizer 
concentration was increasing the diffusion rate of the active substance. Besides, when also 
the polymer combination of Eudragit RS and hydroxypropyl methylcellulose has been used 
with 30% glycerine, an increase in the diffusion rate of valsartan has been determined (Irfani 
et al., 2011). 
In a study, effects of two plasticizers, dibutyl phthalate and dibutyl sebacate, on the 
mechanical properties of the transdermal films prepared with Eudragit 100- 
polyvinylpyrolidone polymer mixture have been researched. It was shown that tensile 
strength was gradually decreased as the plasticizer concentration in the patch increased. It 
can be concluded from this result that plasticizer molecules disrupt the inter-chain cohesive 
forces of the polymer. Dibutyl phthalate and dibutyl sebacate have affected the mechanical 
properties of the transdermal system similarly. The finding that dibutyl sebacate is a 
suitable plasticizer for a more rapid release has been found in conformance with the finding 
of Siepmann and colleagues stating that dibutyl sebacate ensures faster release, whereas 
plasticizers containing phthalate group should be preferred when extended effect is 
required (Rajabalaya et al., 2010; Siepmann et al., 1999). 
In the study where Gum copal has been used as polymer, hydrophobic dibutyl phthalate 
and hydrophilic glycerin and polyethylene glycol 400 have been preferred as plasticizer. It 
has been observed that, the films prepared by using dibutyl phthalate were more 
homogeneous and clear and also, their tensile strength and % elongation values have been 
found higher. In the study where verapamil hydrochloride has taken place as active 
substance, the release has realized longer and more controlled than the films containing 30% 
dibutyl phthalate (Mundada and Avari, 2010).  
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The characterization of the cellulose membranes where polyethylene glycol 600 has been 
used as plasticizer has been made and it has been determined that, besides the plasticizer 
concentration, preparation temperature was also effective on the membrane properties. It 
has been determined that, the membranes prepared at 40°C were more homogeneous and 
the diffusion of the active substance scopolamine, has realized through 3 days, controlled 
and constant, from the membranes containing 10% or 20% polyethylene glycol 600. It has 
been reported that, in order to improve the mechanical properties of the cellulose acetate 
membranes and to enable the linear release of the active substance, polyethylene glycol 
concentration should be optimized (Wang et al., 2002)  
5. Conclusion 
There are several considerations in the optimization of a transdermal drug delivery system. 
The choice and design of polymers, adhesives, penetration enhancers and plasticizers in 
transdermal systems are crucial for drug release characteristics as well as mechanical 
properties of the formulation. Beside the other components of transdermal patches, 
plasticizers also significantly change the viscoelastic properties of the polymers. The reasons 
for the use of plasticizers in transdermal drug delivery systems are the improvement of film 
forming properties and the appearance of the film, preventing film cracking, increasing film 
flexibility and obtaining desirable mechanical properties. Therefore, the selection of the 
plasticizer type and the optimization of its concentration in the formulation should be 
carefully considered. 
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